中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 青岛生物能源与过程研究所
  3. 中国科学院青岛生物能源与过程研究所
  4. 仿真模拟团队
A long-acting PAI-1 inhibitor reduces thrombus formation

文献类型：期刊论文

作者Peng, Shuangzhou1,2,3; Xue, Guangpu1,2,6; Gong, Lihu1,2; Fang, Chao7,8; Chen, Jingfei5; Yuan, Cai4; Chen, Zhuo1,2; Yao, Lishan5; Furie, Bruce7; Huang, Mingdong1,2,4,7
刊名THROMBOSIS AND HAEMOSTASIS
出版日期2017-07-01
卷号117期号:7页码:1338-1347
关键词Pai-1 Inhibitor Human Serum Albumin (Hsa) Thrombosis Clot Lysis
DOI10.1160/TH16-11-0891
文献子类Article
英文摘要Plasminogen activator inhibitor 1 (PAI-1) is the main inhibitor of tissue-type and urokinase-type plasminogen activators (t/uPA) and plays an important role in fibrinolysis. Inhibition of PAI-1 activity prevents thrombosis and accelerates fibrinolysis, indicating that PAI-1 inhibitors may be used as effective antithrombotic agents. We previously designed a PAI-1 inhibitor (PAltrap) which is a variant of inactivated urokinase protease domain. In the present study, we fused PAltrap with human serum albumin (HSA) to develop a long-acting PAI-1 inhibitor. Unfortunately, the fusion protein PAltrap-HSA lost some potency compared to PAltrap (33 nM vs 10 nM). Guided by computational method, we carried out further optimisation to enhance inhibitory potency for PAI-1. The new PAltrap, denominated PAltrap(H37R)-HSA, which was the H37R variant of PAltrap fused to NSA, gave a six-fold improvement of IC50 (5 nM) for human active PAI-1 compared to PAIt-rap-NSA, and showed much longer plasma half-life (200-fold) compared to PAltrap. We further demonstrated that the PAltrap(H37R)-1 HSA inhibited exogenous or endogenous PAI-1 to promote fibrinolysis in fibrin-clot lysis assay. PAltrap(H37R)-HSA inhibits murine PAI-1 with IC50 value of 12 nM, allowing the inhibitor to be evaluated in murine models. Using an intravital microscopy, we demonstrated that PAIt-rap(H37R)-HSA blocks thrombus formation and platelet accumulation in vivo in a laser-induced vascular injury mouse model. Additionally, mouse tail bleeding assay showed that PAltrap(H37R)-HSA did not affect the global haemostasis. These results suggest that PAltrap(H37R)HSA have the potential benefit to prevent thrombosis and accelerates fibrinolysis.
WOS关键词PLASMINOGEN-ACTIVATOR INHIBITOR-1 ; ARTERIAL THROMBOSIS ; IN-VIVO ; MICE ; THROMBOLYSIS ; STABILITY ; GENE ; FIBRINOLYSIS ; DEFICIENCY ; ANTAGONIST
WOS研究方向Hematology ; Cardiovascular System & Cardiology
语种英语
WOS记录号WOS:000404671700014
资助机构Natural Science Foundation of China(31370737 ; Strategic Priority Research Program of the CAS(XDA09030307) ; CAS/SAFEA International Partnership Program for Creative Research Teams ; Thrombosis and Hemostasis Societies of North America ; 31400637 ; 31570745 ; 31670739 ; U1405229)
源URL[http://ir.qibebt.ac.cn/handle/337004/9637]  
专题青岛生物能源与过程研究所_仿真模拟团队
作者单位1.Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou, Fujian, Peoples R China
2.Chinese Acad Sci, Danish Chinese Ctr Proteases & Canc, Fujian Inst Res Struct Matter, Fuzhou, Fujian, Peoples R China
3.Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China
4.Fuzhou Univ, Fuzhou, Fujian, Peoples R China
5.Chinese Acad Sci, Qingdao Inst Biomass Energy & Bioproc Technol, Qingdao, Peoples R China
6.Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China
7.Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA USA
8.Huazhong Univ Sci &Technol, Tongji Med Coll, Sch Basic Med, Huazhong, Peoples R China
推荐引用方式
GB/T 7714		 Peng, Shuangzhou,Xue, Guangpu,Gong, Lihu,et al. A long-acting PAI-1 inhibitor reduces thrombus formation[J]. THROMBOSIS AND HAEMOSTASIS,2017,117(7):1338-1347.
APA Peng, Shuangzhou.,Xue, Guangpu.,Gong, Lihu.,Fang, Chao.,Chen, Jingfei.,...&Huang, Mingdong.(2017).A long-acting PAI-1 inhibitor reduces thrombus formation.THROMBOSIS AND HAEMOSTASIS,117(7),1338-1347.
MLA Peng, Shuangzhou,et al."A long-acting PAI-1 inhibitor reduces thrombus formation".THROMBOSIS AND HAEMOSTASIS 117.7(2017):1338-1347.

入库方式： OAI收割

来源：青岛生物能源与过程研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。